Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo

International Journal of Oncology

Volumn 28, Issue 5, 2006, Pages 1225-1232

  You, Yongping ^a,b   Pu, Peiyu ^a   Huang, Qiang ^a   Xia, Zhibo ^a   Wang, Chunyan ^a   Wang, Guangxiu ^a   Yu, Chunzhao ^b   Yu, Jing Jie ^c   Reed, Eddie ^c   Li, Qingdi Q ^c,d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Antisense human telomerase RNA; Cell proliferation; Gene therapy; Gliomas; hTERT; Human telomerase reverse transcriptase; Telomerase activity

Indexed keywords

ACTIN; COMPLEMENTARY RNA; MESSENGER RNA; PRIMER DNA; TELOMERASE;

ARTICLE; BRAIN TUMOR; CELL DIVISION; DRUG EFFECT; GENETICS; GLIOMA; HUMAN; KINETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ACTINS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; GLIOMA; HUMANS; KINETICS; RNA, ANTISENSE; RNA, MESSENGER; TELOMERASE;

EID: 33646825056     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.5.1225     Document Type: Article

References (23)

1. Kim NW, Piatysrek MA and Prowse KR: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
2. You Y, Pu P and Peng Q: Telomerase activity and regulation in human neuroepithelial tumors. Chin J Surg 40: 90-93, 2002.
3. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
4. Harada K, Arita K and Kurisu K: Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation. Surg Neurol 53: 267-274, 2000.
5. Hiraga S: Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58: 2117-2125, 1998.
6. Kondo Y, Koga S and Komata T: Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. Oncogene 19: 2205-2211, 2000.
7. Mukai S, Kondo Y and Koga S: 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas. Cancer Res 60: 4461-4467, 2000.
8. Komata T, Kondo Y and Kanzawa T: Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res 61: 5796-5802, 2001.
9. Kim NM and Wu F: Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25: 2595-2597, 1997.
10. Hahnfeldt P, Panigrahy D, Folkman J and Hlatky L: Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res 59: 4770-4775, 1999.
11. Nurnberg P, Thiel G and Weber F: Changes of telomere lengths in human intracranial tumors. Hum Genet 91: 190-192, 1993.
12. De Lange T: Telomeres and senescence: ending the debate. Science 279: 334-335, 1998.
13. Harley CB, Futcher AB and Greider CW: Telomeres shorten during age of human fibroblasts. Nature 345: 458-460, 1990.
14. Ariel A, Avilion L and Mieczyslaw A: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650, 1996.
15. Feng J, Funk WD and Sy SW: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
16. Meyerson M, Counter CM and Eaton EN: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997.
17. Suzuki T, Suzuki Y and Fujioka T: Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer. J Urol 162: 2217-2220, 1999.
18. Kyo S, Kanaya T and Takakura M: Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer 80: 60-63, 1999.
19. Harrington L, McPhail T and Mar V: A mammalian telomerase-associated protein. Science 275: 973-977, 1997.
20. Dome JS, Chung S and Bergemann T: High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilm's tumor. Cancer Res 59: 4301-4307, 1999.
21. Hisatomi H, Nagao K and Kanamaru T: Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy. Int J Oncol 14: 717-732, 1999.
22. Simon M, Park TW and Leuenroth S: Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J Neurosurg 92: 832-840, 2000.
23. Beattie TL, Zhou W and Robinson MO: Reconstitution of human telomerase activity in vitro. Curr Biol 8: 177-180, 1998.